Icon has been on a spending spree, they've spent billions acquiring IP and forming at least one recent partnership (Proteome Sciences) that I could find. And the Icon link that I posted suggests, to me at least, that Icon has an interest in Lympro that goes beyond some puny MSA worth 150k which is pocket change for them. Yet, you're attempting to put a negative spin on the info I posted? Interesting. 

Imo, a more substantial lympro partnership with Icon has likely been negotiated and the two companies are waiting for final LP002 results before they finalize the details. But that's just my opinion.